We are live on !
Find out more
Bailard Portfolio holdings
AUM
$4.94B
Turnover
24.33%
1-Year Est. Return
25.15%
This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+25.15%
3 Year Est. Return
+104.94%
5 Year Est. Return
+121.63%
10 Year Est. Return
+438.61%
AUM
$650M
AUM Growth
+$19.6M
(+3.1%)
Cap. Flow
-$8.55M
Cap. Flow % of AUM
Cap. Flow %
-1.31%
Top 10 Holdings %
Top 10 Hldgs %
59.87%
Holding
259
New
44
Increased
68
Reduced
78
Closed
25
Avg Time Held
0.6
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$61.6M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$59.4M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$3.59M |
| 4 |
Verizon
VZ
|
+$2.51M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$2.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$57.8M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$55.8M |
| 3 |
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
|
+$10.3M |
| 4 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$6.5M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$6.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 74.43% |
| 2 | Technology | 5.57% |
| 3 | Healthcare | 4.98% |
| 4 | Industrials | 2.9% |
| 5 | Real Estate | 2.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $80.1M | 12.32% |
409,122
+889
| +0.2% | +$169K |
2013 Q2
4 quarters
|
|
|
2
Invesco QQQ Trust
QQQ
$475B
| $66.9M | 10.29% |
712,264
-67,463
| -9% | -$6.02M |
2013 Q2
4 quarters
|
|
|
3
State Street Energy Select Sector SPDR ETF
XLE
$44.2B
| $65.1M | 10.02% |
+1,301,222
| New | +$61.6M |
2014 Q2
0 quarters
|
|
|
4
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| $61.1M | 9.4% |
1,413,588
+1,400,431
| +10,644% | +$59.4M |
2013 Q2
4 quarters
|
|
|
5
Vanguard Morningstar Total Stock Market ETF
VTI
$690B
| $40.2M | 6.19% |
395,114
-65,915
| -14% | -$6.5M |
2013 Q2
4 quarters
|
|
6
iShares Core US Aggregate Bond ETF
AGG
$140B
| $28.5M | 4.39% |
261,340
+4,624
| +2% | +$503K |
2013 Q2
4 quarters
|
|
|
7
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.51B
| $24M | 3.68% |
492,216
-211,365
| -30% | -$10.3M |
2013 Q2
4 quarters
|
|
8
State Street Financial Select Sector SPDR ETF
XLF
$52.6B
| $7.85M | 1.21% |
393,053
+3,281
| +0.8% | +$63.9K |
2013 Q2
4 quarters
|
|
9
Apple
AAPL
$5.08T
| $7.82M | 1.2% |
336,784
+80,808
| +32% | +$1.72M |
2013 Q2
4 quarters
|
|
10
iShares S&P Small-Cap 600 Value ETF
IJS
$7.65B
| $7.67M | 1.18% |
132,862
-846
| -0.6% | -$47.3K |
2013 Q2
4 quarters
|
|
11
Vanguard Information Technology ETF
VGT
$146B
| $6.55M | 1.01% |
541,416
+17,416
| +3% | +$201K |
2013 Q3
3 quarters
|
|
12
Vanguard Consumer Staples ETF
VDC
$8.22B
| $6.09M | 0.94% |
52,595
+1,685
| +3% | +$192K |
2013 Q3
3 quarters
|
|
13
Vanguard Health Care ETF
VHT
$20.3B
| $5.96M | 0.92% |
53,390
+345
| +0.7% | +$36.9K |
2013 Q3
3 quarters
|
|
14
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.5B
| $5.94M | 0.91% |
112,530
-1,192
| -1% | -$62.9K |
2013 Q2
4 quarters
|
|
15
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$2.96B
| $5.79M | 0.89% |
122,563
-36,719
| -23% | -$1.73M |
2013 Q4
2 quarters
|
|
16
Vanguard Consumer Discretionary ETF
VCR
$5.92B
| $5.76M | 0.89% |
52,720
+850
| +2% | +$89.7K |
2013 Q3
3 quarters
|
|
17
Vanguard Industrials ETF
VIS
$7.97B
| $5.2M | 0.8% |
49,890
+660
| +1% | +$67.5K |
2013 Q3
3 quarters
|
|
18
iShares California Muni Bond ETF
CMF
$5.18B
| $5.16M | 0.79% |
89,252
+2,812
| +3% | +$162K |
2013 Q2
4 quarters
|
|
|
BDSI
19
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $4.8M | 0.74% |
398,000
+55,600
| +16% | +$527K |
2013 Q3
3 quarters
|
|
20
Vanguard Energy ETF
VDE
$11.3B
| $4.42M | 0.68% |
30,718
+943
| +3% | +$128K |
2013 Q3
3 quarters
|
|
21
Johnson & Johnson
JNJ
$645B
| $4.36M | 0.67% |
41,638
+2,265
| +6% | +$229K |
2013 Q2
4 quarters
|
|
22
iShares MSCI EAFE ETF
EFA
$76.6B
| $4.07M | 0.63% |
59,502
-1,290
| -2% | -$88.4K |
2013 Q2
4 quarters
|
|
23
Chevron
CVX
$445B
| $3.99M | 0.61% |
30,575
+1,437
| +5% | +$179K |
2013 Q2
4 quarters
|
|
24
Enanta Pharmaceuticals
ENTA
$338M
| $3.94M | 0.61% |
91,500
+17,194
| +23% | +$656K |
2013 Q3
3 quarters
|
|
|
BT
25
DELISTED
BT Group plc (ADR)
BT
| $3.8M | 0.58% |
115,854
-24
| -0% | -$771 |
2013 Q2
4 quarters
|
|
Similar funds
SL
Bailard's Q2 2014 Portfolio in Review
As of Q2 2014, Bailard held 259 positions worth $650M, up 3.1% from $630M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Bailard's Q2 2014 filing shows 44 new, 68 increased, 78 reduced and 25 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 1,301,222 shares worth $65.1M. The largest sale was iShares US Real Estate ETF, an estimated $57.8M.
By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 75% a quarter earlier, followed by Technology and Healthcare.
- Bailard's largest Q2 2014 buy was State Street Energy Select Sector SPDR ETF: 1,301,222 shares worth $65.1M.
- Bailard added most to iShares MSCI Emerging Markets ETF in Q2 2014, an estimated $59.4M increase.
- Bailard's biggest Q2 2014 reduction was iShares US Real Estate ETF, cutting an estimated $57.8M.
- Bailard fully exited Arbutus Biopharma in Q2 2014, selling an estimated $2.05M.
- Bailard's ten largest holdings make up 60% of its $650M portfolio in Q2 2014.
- Bailard opened 44 new positions and closed 25 in Q2 2014.
- Bailard's portfolio value rose 3.1% quarter-over-quarter to $650M.
Based on Bailard's 13F filing for Q2 2014, filed 30 Jul 2014.